Skip to main content
Home Life Sciences

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2024/06/TUSW-may-2024-featured-image.jpeg

Triangle Universities Startup Workshop: Academic Entrepreneurs Get an Intensive Course in Venture

What does it take to build a therapeutic or medical device startup? Duke, UNC, and NC State – with support from Alexandria Venture Investments – put on a three-day workshop for a select group of…

Read More

https://otc.duke.edu/wp-content/uploads/2024/06/amgen_logo.jpg

AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)

Uplizna, an antibody therapy for immune diseases, is based on technology licensed from Duke University, developed by the late Dr. Thomas Tedder (Immunology, SOM) and colleagues.

Read More

https://otc.duke.edu/wp-content/uploads/2024/06/restor3d_sign.jpg

restor3d Announces Successful Closing of $70 Million Financing

restor3d is a Duke orthopedic medical device start-up spun out of the lab of Professor Ken Gall (MEMS, Pratt). DCP has participated in every round.

Read More

https://otc.duke.edu/wp-content/uploads/2024/05/Piximune-logo.png

ARVO recognizes Daniel R. Saban as a rising star in the world of ophthalmology and visual science

Leading research organization awards Associate Professor Daniel R. Saban (Ophthalmology, SOM) for his contributions to the field. Saban is commercializing this research through Duke University start-up Piximune Therapeutics.

Read More

https://otc.duke.edu/wp-content/uploads/2024/04/LumiSystem_Family_withoutLogo_v5-1000.jpg

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell is an MIT start-up based on breast cancer imaging technology co-developed by Dr. David Kirsch (Radiation Oncology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/04/plug-and-play-logo.png

Plug and Play Announces Inaugural Batch of Startups Selected for their Medtech Program

Duke start-up Sparta Biomedical has been selected for Batch 1 of Plug and Play's Warsaw Medtech program in Spring 2024.

Read More

https://otc.duke.edu/wp-content/uploads/2024/03/meyer_kate_magnify.png

The Power and Promise of RNA

Several Duke researchers studying RNA modification are profiled in this Magnify article from the School of Medicine. Tech available for licensing!

Read More

https://otc.duke.edu/wp-content/uploads/2024/03/TechCommBootcamp_20240223_5862.jpg

Transforming inventions into products: Duke charts a path for student innovators

Duke’s innovation ecosystem collaborates to offer Duke graduate and professional students a hands-on technology commercialization bootcamp – focused on student-led inventions.

Read More

https://otc.duke.edu/wp-content/uploads/2023/10/BMI_OrganBank_Logo.jpg

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation’s First Organ Banking Technology

BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).

Read More

1 2 3 27